CompletedPhase 2NCT02629991

Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome

Studying Prader-Willi syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Montefiore Medical Center
Principal Investigator
Eric Hollander, MD
Montefiore Medical Center
Intervention
Intranasal Oxytocin (IN-OXT)(drug)
Enrollment
23 enrolled
Eligibility
5-18 years · All sexes
Timeline
20152018

Study locations (1)

Collaborators

Foundation for Prader-Willi Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02629991 on ClinicalTrials.gov

Other trials for Prader-Willi syndrome

Additional recruiting or active studies for the same condition.

See all trials for Prader-Willi syndrome

← Back to all trials